| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Kakkis Emil D is a President &CEO at RARE. Recent filings cover 3 purchases and 51 sales.
Our model assigns Kakkis Emil D a strong insider score of 72/100, based on 11 past trades. Over a 12-month horizon, 72.7% of those trades were profitable, with an average 12-month return of +20.0%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 98,434 | $42.20 | $4,153,571.40 | -4.4% | -12.4% | -46.5% | |
| Dec 30, 2024 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 11,727 | $42.23 | $495,231.21 | -0.5% | -14.3% | -46.1% | |
| Dec 10, 2024 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 8,273 | $50.00 | $413,650.00 | -0.4% | -23.6% | -26.7% | |
| Sep 3, 2024 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $55.85 | $1,117,000.00 | -0.9% | -14.6% | -43.4% | |
| Aug 6, 2024 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 20,000 | $50.17 | $1,003,400.00 | -0.9% | +2.6% | -43.6% | |
| Feb 7, 2024 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 30,000 | $45.00 | $1,350,000.00 | -5.3% | -6.2% | +2.4% | |
| Dec 29, 2023 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 30,000 | $47.87 | $1,436,100.00 | -5.0% | -2.4% | -9.2% | |
| Oct 19, 2023 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sale+OE | 47,853 | $33.52 | $1,604,032.56 | -7.4% | +29.9% | +68.2% | |
| Dec 30, 2022 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 19,582 | $45.57 | $892,351.74 | -3.5% | -16.6% | +3.2% | |
| May 3, 2021 | RARE Ultragenyx Pharmaceutical Inc. | President &CEO | Sell | 30,000 | $107.80 | $3,234,000.00 | -1.3% | -24.1% | -32.9% |